FAAH2
Fatty-acid amide hydrolase 2
Also known as: AMDD, FAAH-2, FAAH2_HUMAN, FLJ31204, RP11-479E16.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6GMR7
- Gene
- FAAH2
- Ensembl
- ENSG00000165591
- Chromosome
- X
- Canonical length
- 532 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a fatty acid amide hydrolase that shares a conserved protein motif with the amidase signature family of enzymes. The encoded enzyme is able to catalyze the hydrolysis of a broad range of bioactive lipids, including those from the three main classes of fatty acid amides; N-acylethanolamines, fatty acid primary amides and N-acyl amino acids. This enzyme has a preference for monounsaturated acyl chains as a substrate. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
532 residues, UniProt reviewed canonical sequence.
>Q6GMR7|FAAH2
1 MAPSFTARIQ LFLLRALGFL IGLVGRAALV LGGPKFASKT PRPVTEPLLL LSGMQLAKLI
61 RQRKVKCIDV VQAYINRIKD VNPMINGIVK YRFEEAMKEA HAVDQKLAEK QEDEATLENK
121 WPFLGVPLTV KEAFQLQGMP NSSGLMNRRD AIAKTDATVV ALLKGAGAIP LGITNCSELC
181 MWYESSNKIY GRSNNPYDLQ HIVGGSSGGE GCTLAAACSV IGVGSDIGGS IRMPAFFNGI
241 FGHKPSPGVV PNKGQFPLAV GAQELFLCTG PMCRYAEDLA PMLKVMAGPG IKRLKLDTKV
301 HLKDLKFYWM EHDGGSFLMS KVDQDLIMTQ KKVVVHLETI LGASVQHVKL KKMKYSFQLW
361 IAMMSAKGHD GKEPVKFVDL LGDHGKHVSP LWELIKWCLG LSVYTIPSIG LALLEEKLRY
421 SNEKYQKFKA VEESLRKELV DMLGDDGVFL YPSHPTVAPK HHVPLTRPFN FAYTGVFSAL
481 GLPVTQCPLG LNAKGLPLGI QVVAGPFNDH LTLAVAQYLE KTFGGWVCPG KFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAAH2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 14 nTPM
- parathyroid gland: 13 nTPM
- liver: 9.8 nTPM
- skin: 9.2 nTPM
- prostate: 6.9 nTPM
- thymus: 6.8 nTPM
Single-cell type
- pancreatic acinar cells: 458 nCPM
- somatotrophs: 413 nCPM
- thyrotrophs: 364 nCPM
- lactotrophs: 363 nCPM
- plasma cells: 303 nCPM
- prostatic glandular cells: 294 nCPM
Immune cell
- T-reg: 17 nTPM
- memory CD4 T-cell: 8 nTPM
- naive CD4 T-cell: 7.8 nTPM
- MAIT T-cell: 5 nTPM
- memory CD8 T-cell: 3.4 nTPM
- memory B-cell: 1.8 nTPM
Brain region
- cerebellum: 8.1 nTPM
- hypothalamus: 6.8 nTPM
- midbrain: 4 nTPM
- medulla oblongata: 3.7 nTPM
- pons: 3.7 nTPM
- basal ganglia: 3.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FAAH2.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 222 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.94
- gnomAD pLI
- 0
- gnomAD missense Z
- -3.63
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Amidase, conserved site
- Amidase signature domain
- Amidase signature (AS) superfamily
- Amidase
- Fatty-acid amide hydrolase 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAAH2 as an antibody target. Whether an autoantibody or antibody against FAAH2 could matter depends on whether native FAAH2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAAH2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAAH2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...